Bio Logic MateTM clinical performance test for IFX Efficacy predictio
Not Applicable
- Conditions
- rheumatoid arthritis
- Registration Number
- JPRN-UMIN000009088
- Lead Sponsor
- Bio Logic Mate Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
1. Be against the guideline of IFX and MTX. 2. Paitient is otherwise ineligible to participate in this study in the investigator's opinion.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ADAMTS5mRNA dose at 0W estimation at 14W(DAS28).
- Secondary Outcome Measures
Name Time Method CDAI,SDAI,Boolean Definition estimation at 14W(CDAI,SDAI,Boolean Definition)estimation at 52W(CDAI,SDAI,Boolean Definition).